28 research outputs found

    Some results about diagonal operators on Köthe echelon spaces

    Full text link
    [EN] Several questions about diagonal operators between Köthe echelon spaces are investigated: (1) The spectrum is characterized in terms of the Köthe matrices defining the spaces, (2) It is characterized when these operators are power bounded, mean ergodic or uniformly mean ergodic, and (3) A description of the topology in the space of diagonal operators induced by the strong topology on the space of all operators is given.This research was partially supported by MINECO Project MTM2016-76647-P and the grant PAID-01-16 of the Universitat Politècnica de València.Rodríguez-Arenas, A. (2019). Some results about diagonal operators on Köthe echelon spaces. Revista de la Real Academia de Ciencias Exactas Físicas y Naturales Serie A Matemáticas. 113(4):2959-2968. https://doi.org/10.1007/s13398-019-00663-yS295929681134Agathen, S., Bierstedt, K.D., Bonet, J.: Projective limits of weighted (LB)-spaces of continuous functions. Arch. Math. 92, 384–398 (2009)Albanese, A.A., Bonet, J., Ricker, W.J.: Mean ergodic operators in Fréchet spaces. Ann. Acad. Sci. Fenn. Math. 34(2), 401–436 (2009)Bennett, G.: Some elementary inequalities. Quart. J. Math. 38, 401–425 (1987)Bennett, G.: Factorizing the classical inequalities. Mem. Am. Math. Soc. (1996). https://doi.org/10.1090/memo/0576Bierstedt, K.D.: An introduction to locally convex inductive limits, Functional analysis and its applications (Nice, 1986), 35–133, ICPAM Lecture Notes. World Sci. Publishing, Singapore (1988)Bierstedt, K.D., Bonet, J.: Some aspects of the modern theory of Fréchet spaces. Rev. R. Acad. Cienc. Exactas Fís. Nat. Ser. A Mat. 97(2), 159–188 (2003)Bierstedt, K.D., Meise, R., Summers, W.H.: Köthe sets and Köthe sequence spaces, Functional Analysis, Holomorphy and Approximation Theory. North-Holland Math. Studies 71, 27–91 (1982)Bonet, J., Jordá, E., Rodríguez-Arenas, A.: Mean ergodic multiplication operators on weighted spaces of continuous functions. Mediterr. J. Math 15, 108 (2018)Crofts, G.: Concerning perfect Fréchet spaces and transformations. Math. Ann. 182, 67–76 (1969)Kellogg, C.N.: An extension of the Hausdorff–Young theorem. Michig. Math. J. 18, 121–127 (1971)Krengel, U.: Ergodic Theorems. de Gruyter, Berlin (1985)Meise, R., Vogt, D.: Introduction to Functional Analysis. Oxford University Press, New York (1997)Vasilescu, F.H.: Analytic Functional Calculus and Spectral Decompositions. D. Reidel Publ. Co., Dordrecht (1982)Wengenroth, J.: Derived Functors in Functional Analysis. Springer, Berlin (2003)Yosida, K.: Functional Analysis. Springer, Berlin (1980

    Income in Adult Survivors of Childhood Cancer.

    Get PDF
    INTRODUCTION: Little is known about the impact of childhood cancer on the personal income of survivors. We compared income between survivors and siblings, and determined factors associated with income. METHODS: As part of the Swiss Childhood Cancer Survivor Study (SCCSS), a questionnaire was sent to survivors, aged ≥18 years, registered in the Swiss Childhood Cancer Registry (SCCR), diagnosed at age 4'500 CHF), even after we adjusted for socio-demographic and educational factors (OR = 0.46, p<0.001). Older age, male sex, personal and parental education, and number of working hours were associated with high income. Survivors of leukemia (OR = 0.40, p<0.001), lymphoma (OR = 0.63, p = 0.040), CNS tumors (OR = 0.22, p<0.001), bone tumors (OR = 0.24, p = 0.003) had a lower income than siblings. Survivors who had cranial irradiation, had a lower income than survivors who had no cranial irradiation (OR = 0.48, p = 0.006). DISCUSSION: Even after adjusting for socio-demographic characteristics, education and working hours, survivors of various diagnostic groups have lower incomes than siblings. Further research needs to identify the underlying causes

    Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

    Get PDF
    Introduction: The use of anti-retroviral therapy (ART) has dramatically reduced HIV-1 associated morbidity and mortality. However, HIV-1 infected individuals have increased rates of morbidity and mortality compared to the non-HIV-1 infected population and this appears to be related to end-organ diseases collectively referred to as Serious Non-AIDS Events (SNAEs). Circulating miRNAs are reported as promising biomarkers for a number of human disease conditions including those that constitute SNAEs. Our study sought to investigate the potential of selected miRNAs in predicting mortality in HIV-1 infected ART treated individuals. Materials and Methods: A set of miRNAs was chosen based on published associations with human disease conditions that constitute SNAEs. This case: control study compared 126 cases (individuals who died whilst on therapy), and 247 matched controls (individuals who remained alive). Cases and controls were ART treated participants of two pivotal HIV-1 trials. The relative abundance of each miRNA in serum was measured, by RTqPCR. Associations with mortality (all-cause, cardiovascular and malignancy) were assessed by logistic regression analysis. Correlations between miRNAs and CD4+ T cell count, hs-CRP, IL-6 and D-dimer were also assessed. Results: None of the selected miRNAs was associated with all-cause, cardiovascular or malignancy mortality. The levels of three miRNAs (miRs -21, -122 and -200a) correlated with IL-6 while miR-21 also correlated with D-dimer. Additionally, the abundance of miRs -31, -150 and -223, correlated with baseline CD4+ T cell count while the same three miRNAs plus miR- 145 correlated with nadir CD4+ T cell count. Discussion: No associations with mortality were found with any circulating miRNA studied. These results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection

    Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    Get PDF
    Ristola M. on työryhmien DAD Study Grp ; Royal Free Hosp Clin Cohort ; INSIGHT Study Grp ; SMART Study Grp ; ESPRIT Study Grp jäsen.Background Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and implementation of a risk score model for CKD would allow comparison of the risks and benefits of adding potentially nephrotoxic antiretrovirals to a treatment regimen and would identify those at greatest risk of CKD. The aims of this study were to develop a simple, externally validated, and widely applicable long-term risk score model for CKD in HIV-positive individuals that can guide decision making in clinical practice. Methods and Findings A total of 17,954 HIV-positive individuals from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study with >= 3 estimated glomerular filtration rate (eGFR) values after 1 January 2004 were included. Baseline was defined as the first eGFR > 60 ml/min/1.73 m2 after 1 January 2004; individuals with exposure to tenofovir, atazanavir, atazanavir/ritonavir, lopinavir/ritonavir, other boosted protease inhibitors before baseline were excluded. CKD was defined as confirmed (>3 mo apart) eGFR In the D:A:D study, 641 individuals developed CKD during 103,185 person-years of follow-up (PYFU; incidence 6.2/1,000 PYFU, 95% CI 5.7-6.7; median follow-up 6.1 y, range 0.3-9.1 y). Older age, intravenous drug use, hepatitis C coinfection, lower baseline eGFR, female gender, lower CD4 count nadir, hypertension, diabetes, and cardiovascular disease (CVD) predicted CKD. The adjusted incidence rate ratios of these nine categorical variables were scaled and summed to create the risk score. The median risk score at baseline was -2 (interquartile range -4 to 2). There was a 1: 393 chance of developing CKD in the next 5 y in the low risk group (risk score = 5, 505 events), respectively. Number needed to harm (NNTH) at 5 y when starting unboosted atazanavir or lopinavir/ritonavir among those with a low risk score was 1,702 (95% CI 1,166-3,367); NNTH was 202 (95% CI 159-278) and 21 (95% CI 19-23), respectively, for those with a medium and high risk score. NNTH was 739 (95% CI 506-1462), 88 (95% CI 69-121), and 9 (95% CI 8-10) for those with a low, medium, and high risk score, respectively, starting tenofovir, atazanavir/ritonavir, or another boosted protease inhibitor. The Royal Free Hospital Clinic Cohort included 2,548 individuals, of whom 94 individuals developed CKD (3.7%) during 18,376 PYFU (median follow-up 7.4 y, range 0.3-12.7 y). Of 2,013 individuals included from the SMART/ESPRIT control arms, 32 individuals developed CKD (1.6%) during 8,452 PYFU (median follow-up 4.1 y, range 0.6-8.1 y). External validation showed that the risk score predicted well in these cohorts. Limitations of this study included limited data on race and no information on proteinuria. Conclusions Both traditional and HIV-related risk factors were predictive of CKD. These factors were used to develop a risk score for CKD in HIV infection, externally validated, that has direct clinical relevance for patients and clinicians to weigh the benefits of certain antiretrovirals against the risk of CKD and to identify those at greatest risk of CKD.Peer reviewe

    Review

    No full text

    Wissensproduktion und Wissenstransfer: Zur Einleitung

    No full text
    Das Ziel der Förderinitiative "Wissen für Entscheidungsprozesse" bestand darin, die vielfältigen Wechselwirkungen zwischen Wissenschaft, Politik und Gesellschaft aufzuzeigen. Hierzu sollten nicht nur die (sozial-) wissenschaftliche Beratungskompetenz für forschungs- und wissenschaftspolitische Entscheidungen gestärkt, sondern auch Strategien zur Erhöhung der Leistungsfähigkeit und Glaubwürdigkeit der Wissenschaft sowie Instrumente und Kriterien zur Qualitätssicherung der wissenschaftlichen Expertise entwickelt werden. Durch die Förderinitiative des Bundesministeriums für Bildung und Forschung konnten vor allem die Projektinteressen von überwiegend jüngeren Wissenschaftlern und Wissenschaftlerinnen geweckt werden. In der vorliegenden Einleitung werden die zwölf geförderten Projekte überblicksartig vorgestellt und thematisch so miteinander verknüpft, dass der inhaltliche Ertrag der Förderinitiative erkennbar wird. Die beiden großen Themenkomplexe beziehen sich zum einen auf die Wissensentwicklungen und Wissenschaftsbedingungen und zum anderen auf die Vermittlungskontexte und Verwendungsprobleme wissenschaftlichen Wissens in Politik und Öffentlichkeit
    corecore